Ebola Patients May Have to Go Without Experimental Drugs in Trial

U.S. health officials reportedly want some Ebola patients to go without experimental treatments so they can compare their reactions to patients who do receive the drugs, as part of a formal trial. The patients who forgo the experimental drugs would still receive standard supportive care, according to Bloomberg, which cited an official involved in the discussions. Benjamin Haynes, senior press officer at the Centers for Disease Control and Prevention said he is unaware of the reported plans. In a prepared testimony before the U.S. House Subcommittee on Oversight and Investigations on Thursday, Dr. Tom Frieden, director of the CDC, said he remains confident that Ebola is not a significant public health threat to the United States.